suplatast tosilate

01/01/2014 - "Treatment with suplatast tosilate was effective in improving all histopathological parameters in a mouse model of chronic asthma. "
01/01/2003 - "Treatment with suplatast tosilate improved pulmonary function in patients with bronchial asthma. "
09/01/2005 - "In the present study, we attempted to clarify the effect of suplatast tosilate on DC1/DC2 balance in asthma. "
06/01/2014 - "Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study."
01/01/2014 - "The effects of suplatast tosilate treatment and prophylaxis on lung histopathology in a mouse model of chronic asthma."

07/01/2013 - "Suplatast tosilate ameliorates airway hyperreactivity and inflammation through inhibition of the GATA‑3/IL‑5 signaling pathway in asthmatic rats."
01/01/2010 - "Suplatast tosilate might suppress this inflammation by inhibiting eotaxin production."
03/01/2007 - "Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation."
09/01/2004 - "Through inhibition of chemotaxis, IPD-1151T might limit the number of eosinophils at the inflammation site. "
07/01/1999 - "Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs."

11/01/2003 - "From the above mentioned results, we confirmed the high efficacy of suplatast tosilate in the treatment of atopic dermatitis."
11/01/2003 - "[The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters]."
12/01/2000 - "From the above mentioned results, the high efficacy and safety of suplatast tosilate in the treatment of severe atopic dermatitis were confirmed. "
12/01/2000 - "[The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis]."
03/01/1999 - "This study was designed to elucidate the mechanisms of the rebound phenomenon, and to test the effect of an oral anti-allergic medication, suplatast tosilate, on atopic dermatitis. "

04/01/1998 - "Suplatast tosilate (IPD), a new immunoregulator, is effective in vitiligo treatment."
04/01/1998 - "In this study, seven patients with vitiligo treated with suplatast tosilate (IPD), three showed repigmentation and improvement of their lesions after administration of the drug. "
01/01/2016 - "Vitiligo-like depigmentation with perifollicular pigment retention in systemic sclerosis treated successfully with suplatast tosilate."

01/01/2009 - "Thus, suplatast tosilate, which is already widely used in Japan, may warrant further consideration as a potentially useful treatment for pulmonary fibrosis."
01/01/2009 - "We found that the treatment of mice with suplatast tosilate significantly reduced the degree of pulmonary fibrosis. "
01/01/2009 - "Therefore, we hypothesized that suplatast tosilate might have an inhibitory effect on the development of pulmonary fibrosis. "
01/01/2019 - "Suplatast tosilate suppressed both oxidative stress markers and the levels of cytokines, which resulted in reduced pulmonary fibrosis and clearly improved the survival rate after irradiation. "
01/01/2009 - "Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice."